Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: J Cardiothorac Vasc Anesth. 2018 Aug 31;33(4):976–984. doi: 10.1053/j.jvca.2018.08.201

Table 1.

Study Demographics

Characteristic Value (Mean ± Standard Deviation/Number of Patients [%])
Male sex (n) 22/30 (73.3)
Age (y) 62.2 ± 11.5
Weight (kg) 88.9 ± 18.9
Procedure (n)
    CABG 10 (33.3)
    Valve repair or replacement 10 (33.3)
    CABG/valve repair or replacement 3 (10.0)
    VAD 3 (10.0)
    Other 4 (13.3)
CPB time (min) 124.1 ± 60.1
Cross-clamp time (min) 76.0 ± 43.7
Preoperative medications (n)
    Aspirin 20 (66.6)
    Heparin 14 (46.6)
    V-K antagonists 6 (20)
    P2Y12 antagonists 2 (6.6)
    Direct thrombin inhibitors 0 (0)
    FXa inhibitors 1 (0.3)
Volume of cell saver administered (mL) 1095.2 ± 921.8

Abbreviations: CAGB, coronary artery bypass grafting; CPB, cardiopulmonary bypass; FXa, Factor Xa; VAD, ventricular assist device; V-K, vitamin K.